QLM3004

· Qilu Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QLM3004, covering 2023-11-30 to 2023-11-30. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3 Clinical Study of QLM3004 in Delaying Myopia in Children [Phase 3]